DCF Advisers’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,500
Closed -$3.18M 81
2022
Q3
$3.18M Buy
+52,500
New +$1.66M 2.06% 14
2022
Q2
Sell
-2,500
Closed -$91K 84
2022
Q1
$91K Buy
+2,500
New +$90.1K 0.04% 64

Other funds holding PRTA

DCF Advisers's PRTA Position: Q2 2026 in Review

DCF Advisers held its Prothena Corp (PRTA) position steady in Q2 2026 at 73,247 shares worth $717K. The position accounts for 0.13% of the portfolio, ranked #71.

DCF Advisers first reported a position in PRTA in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.79M in Q2 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • DCF Advisers held 73,247 shares of Prothena Corp worth $717K as of Q2 2026.
  • DCF Advisers left its Prothena Corp share count unchanged in Q2 2026.
  • Prothena Corp made up 0.13% of DCF Advisers's portfolio in Q2 2026, its #71 holding.
  • DCF Advisers first reported a position in Prothena Corp in Q1 2021 and has held it in 22 quarters since.
  • DCF Advisers's Prothena Corp position peaked at $5.79M in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.